2022 So far In Venture Capital
Zura Bio signs merger deal with JATT Acquisition
The boards of directors of Zura Bio and JATT granted approval for the business combination.
J&J enters $99m opioid settlement deal with West Virginia
Supersized Asia and Africa deal to make Merck pill but Covid drug shortage persists
Ligand signs merger agreement with Avista Public Acquisition
Quoin expands distribution deal with ER-Kim for Netherton Syndrome therapy
PharmaLex enters merger deal with Ascent Development Services
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
